Recent Progress in the Treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
b'Host: Daniel J. George, MD
\\n\\n Host: Fred Saad, MD, FRCS
\\n\\n\\n \\n
The ASCO Genitourinary (ASCO GU) and the Annual ASCO meetings are the leading educational and scientific events for oncologists, urologists, and the cancer team, providing the latest clinical and scientific data from clinical trials and basic and translational research in GU cancer. Thousands of abstracts summarizing state-of-the-art treatment modalities and novel therapies for patients with Prostate Cancer will be presented and it will be critical that educational programing provide learners with not only key data, but interpretation by faculty as to how best to incorporate into clinical practice.
'